Company Accounts and Tax Online 08556296 Board of Directors 1.7.24 30.6.25 30.6.25 false iso4217:GBP xbrli:pure 08556296 2023-07-01 2024-06-30 08556296 2025-06-30 08556296 2024-07-01 2025-06-30 08556296 2024-06-30 08556296 countries:EnglandWales 2024-07-01 2025-06-30 08556296 curr:PoundSterling 2024-07-01 2025-06-30 08556296 uk-bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 08556296 uk-bus:FRS102 2024-07-01 2025-06-30 08556296 uk-bus:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 08556296 uk-bus:FullAccounts 2024-07-01 2025-06-30 08556296 uk-bus:RegisteredOffice 2024-07-01 2025-06-30 08556296 uk-bus:Director1 2024-07-01 2025-06-30 08556296 uk-bus:Director1 2024-07-01 08556296 uk-bus:Director1 2025-06-30 08556296 core:AfterOneYear 2025-06-30 08556296 core:AfterOneYear 2024-06-30 08556296 core:WithinOneYear 2025-06-30 08556296 core:WithinOneYear 2024-06-30 08556296 core:WithinOneYear 2024-07-01 2025-06-30 08556296 core:AfterOneYear 2025-06-30 08556296 core:AfterOneYear 2024-06-30 08556296 core:AfterOneYear 2024-07-01 2025-06-30 08556296 core:ShareCapital 2025-06-30 08556296 core:ShareCapital 2024-06-30 08556296 core:RevaluationReserve 2025-06-30 08556296 core:RevaluationReserve 2024-06-30 08556296 core:RetainedEarningsAccumulatedLosses 2025-06-30 08556296 core:RetainedEarningsAccumulatedLosses 2024-06-30 08556296 1 2024-07-01 2025-06-30 08556296 core:LandBuildings 2024-07-01 2025-06-30 08556296 core:LandBuildings 2025-06-30 08556296 core:LandBuildings 2023-07-01 2024-06-30 08556296 core:LandBuildings 2024-06-30 08556296 core:PlantMachinery 2024-07-01 2025-06-30 08556296 core:PlantMachinery 2025-06-30 08556296 core:PlantMachinery 2023-07-01 2024-06-30 08556296 core:PlantMachinery 2024-06-30 08556296 core:FurnitureFittingsToolsEquipment 2024-07-01 2025-06-30 08556296 core:FurnitureFittingsToolsEquipment 2025-06-30 08556296 core:FurnitureFittingsToolsEquipment 2023-07-01 2024-06-30 08556296 core:FurnitureFittingsToolsEquipment 2024-06-30 08556296 core:OfficeEquipment 2024-07-01 2025-06-30 08556296 core:OfficeEquipment 2025-06-30 08556296 core:OfficeEquipment 2023-07-01 2024-06-30 08556296 core:OfficeEquipment 2024-06-30 08556296 core:Vehicles 2024-07-01 2025-06-30 08556296 core:Vehicles 2025-06-30 08556296 core:Vehicles 2023-07-01 2024-06-30 08556296 core:Vehicles 2024-06-30 08556296 core:NetGoodwill 2024-07-01 2025-06-30 08556296 core:NetGoodwill 2025-06-30 08556296 core:NetGoodwill 2023-07-01 2024-06-30 08556296 core:NetGoodwill 2024-06-30 08556296 core:IntangibleAssetsOtherThanGoodwill 2024-07-01 2025-06-30 08556296 core:IntangibleAssetsOtherThanGoodwill 2025-06-30 08556296 core:IntangibleAssetsOtherThanGoodwill 2023-07-01 2024-06-30 08556296 core:IntangibleAssetsOtherThanGoodwill 2024-06-30

# NEWTONE PHARMA LIMITED

## Company Registration Number:
08556296 (England and Wales)

## Unaudited statutory accounts for the year ended 30 June 2025

## Period of accounts

## Start date: 01 July 2024

## End date: 30 June 2025

# NEWTONE PHARMA LIMITED

## Contents of the Financial Statements

for the Period Ended 30 June 2025

Company Information - 3 |
Report of the Directors - 4 |
Profit and Loss Account - 5 |
Balance sheet - 6 |
Additional notes - 8 |
Balance sheet notes - 11 |

# NEWTONE PHARMA LIMITED

## Company Information

for the Period Ended 30 June 2025

Director: |  | Chrysovalentine GARRETT
Registered office: |  | Suite 23018 8 Shepherd Market Mayfair London England W1J 7JY
Company Registration Number: |  | 08556296 (England and Wales)

# NEWTONE PHARMA LIMITED

## Directors' Report Period Ended 30 June 2025

The directors present their report with the financial statements of the company for the period ended 30 June 2025

Principal Activities

Wholesale of sugar and chocolate and sugar confectionery Wholesale of pharmaceutical goods Non-specialised wholesale trade

Directors

The directors shown below have held office during the whole of the period from 01 July 2024 to 30 June 2025
Chrysovalentine GARRETT

This report was approved by the board of directors on 27 October 2025
And Signed On Behalf Of The Board By:

Name: Chrysovalentine GARRETT
Status: Director

# NEWTONE PHARMA LIMITED

## Profit and Loss Account

for the Period Ended 30 June 2025

| Notes | 2025 £ | 2024 £
--- | --- | --- | ---
Turnover |  | 879,268 | 1,014,584
Cost of sales |  | ( 837,351 ) | ( 970,481 )
Gross Profit or (Loss) |  | 41,917 | 44,103
Administrative Expenses |  | ( 1,986 ) | ( 1,774 )
Operating Profit or (Loss) |  | 39,931 | 42,329
Profit or (Loss) Before Tax |  | 39,931 | 42,329
Tax on Profit |  | ( 7,587 ) | ( 8,043 )
Profit or (Loss) for Period |  | 32,344 | 34,286

The notes form part of these financial statements

# NEWTONE PHARMA LIMITED

## Balance sheet

As at 30 June 2025

| Notes | 2025 £ | 2024 £
--- | --- | --- | ---
Fixed assets
Intangible assets: | 4 | 59,246 | 59,246
Total fixed assets: |  | 59,246 | 59,246
Current assets
Cash at bank and in hand: |  | 7,167 | 17,689
Total current assets: |  | 7,167 | 17,689
Creditors: amounts falling due within one year: | 5 | ( 7,587 ) | ( 8,043 )
Net current assets (liabilities): |  | ( 420 ) | 9,646
Total assets less current liabilities: |  | 58,826 | 68,892
Creditors: amounts falling due after more than one year: | 6 | ( 225,813 ) | ( 275,813 )
Total net assets (liabilities): |  | ( 166,987 ) | ( 206,921 )

The notes form part of these financial statements

# NEWTONE PHARMA LIMITED

## Balance sheet continued

As at 30 June 2025

| Notes | 2025 £ | 2024 £
--- | --- | --- | ---
Capital and reserves
Called up share capital: |  | 1,000 | 1,000
Profit and loss account: |  | ( 167,987 ) | ( 207,921 )
Shareholders funds: |  | ( 166,987 ) | ( 206,921 )

For the year ending 30 June 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 27 October 2025
And Signed On Behalf Of The Board By:

Name: Chrysovalentine GARRETT
Status: Director

The notes form part of these financial statements

# NEWTONE PHARMA LIMITED

## Notes to the Financial Statements

for the Period Ended 30 June 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

  Turnover policy

  Turnover represents the invoiced value of goods and services supplied by the company, net of value-added tax and trade discounts.

# NEWTONE PHARMA LIMITED

## Notes to the Financial Statements

for the Period Ended 30 June 2025

- ## 2. Employees

  | 2025 | 2024
  --- | --- | ---
  Average number of employees during the period | 0 | 0

# NEWTONE PHARMA LIMITED

## Notes to the Financial Statements

for the Period Ended 30 June 2025

- ## 3. Off balance sheet disclosure

  No

# NEWTONE PHARMA LIMITED

## Notes to the Financial Statements

for the Period Ended 30 June 2025

## 4. Intangible assets

| Other | Total
--- | --- | ---
Cost | £ | £
At 01 July 2024 | 59,246 | 59,246
Additions | - | -
Disposals | - | -
Revaluations | - | -
Transfers | - | -
At 30 June 2025 | 59,246 | 59,246
Amortisation |  |
Amortisation at 01 July 2024 | - | -
Charge for year | - | -
On disposals | - | -
Other adjustments | - | -
Amortisation at 30 June 2025 | - | -
Net book value |  |
Net book value at 30 June 2025 | 59,246 | 59,246
Net book value at 30 June 2024 | 59,246 | 59,246

Investments

# NEWTONE PHARMA LIMITED

## Notes to the Financial Statements

for the Period Ended 30 June 2025

## 5.Creditors: amounts falling due within one year note

| 2025 £ | 2024 £
--- | --- | ---
Other creditors | 7,587 | 8,043
Total | 7,587 | 8,043

Corporation tax payable

# NEWTONE PHARMA LIMITED

## Notes to the Financial Statements

for the Period Ended 30 June 2025

## 6.Creditors: amounts falling due after more than one year

| 2025 £ | 2024 £
--- | --- | ---
Other creditors | 225,813 | 275,813
Total | 225,813 | 275,813